Management of bone mineral density in HIV-infected patients

Eugenia Negredo, Anna Bonjoch, Bonaventura Clotet

Research output: Contribution to journalReview articleResearchpeer-review

3 Citations (Scopus)

Abstract

© 2016 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Loss of bone mineral density is an emerging problem in persons living with HIV infection. Earlier and more rapid bone demineralization has been attributed not only to the high prevalence of traditional risk factors, but also to specific HIV-related factors. The aim of this guidance is to stimulate an appropriate management of osteoporosis in this population, to identify patients at risk and to better manage them.Areas covered: Appropriate screening of HIV-infected subjects to identify those at risk for bone fractures is described, as well as the recommended interventions. American and European recommendations in HIV-infected and non-infected populations were considered. As the etiology of bone loss is multifactorial, many factors have to be addressed. Overall, recommendations on traditional risk factors are the same for HIV-infected and non-HIV-infected subjects. However, we should consider some specific factors in the HIV-infected population, including an appropriate antiretroviral therapy in patients with low bone mineral density, and probably novel strategies that could provide an additional benefit, such as anti-inflammatory drugs, although data supporting this approach are scant.Expert opinion: Some personal opinions are highlighted on the management of bone health in HIV-infected subjects, mainly on the use of FRAX® score and DXA scans. In addition, the need to implement new strategies to delay demineralization is remarked upon.
Original languageEnglish
Pages (from-to)845-852
JournalExpert Opinion on Pharmacotherapy
Volume17
Issue number6
DOIs
Publication statusPublished - 12 Apr 2016

Keywords

  • Bone mineral density
  • HIV
  • management
  • Osteoporosis

Fingerprint

Dive into the research topics of 'Management of bone mineral density in HIV-infected patients'. Together they form a unique fingerprint.

Cite this